Propranolol Combined With Novel Endocrine Therapy and Androgen Deprivation Therapy (ADT) for Neoadjuvant Treatment in High-Risk Prostate Cancer Patients: A Multicenter, Single-Arm Clinical Study

NCT07311915 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Propranolol combined with novel endocrine therapy and androgen deprivation therapy

Sponsor

Zhongda Hospital